Login / Signup

Multidisciplinary management of auto-immune ocular diseases in adult patients by ophthalmologists and rheumatologists.

Rianne Elise van BentumJesse M van den BergSanne E WolfJoyce Van der BijlH Stevie TanFrank D VerbraakIrene E van der Horst-Bruinsma
Published in: Acta ophthalmologica (2020)
This evaluation of an MDA-programme in the management of AIOD demonstrated its added value. Mainly, it addressed the high demand for support in managing systemic immunosuppression, resulting in significant corticosteroid tapering. In addition, it resulted in the recognition of underlying systemic diseases.
Keyphrases
  • clinical trial
  • breast cancer cells
  • drug induced
  • cell cycle arrest